Newnex
Get Access

Platform

Syndication and co-investment for institutional venture capital.

Direct, peer to peer. No SPV. Private by default. Invite only.

We understand institutional investing. Newnex is built around it.

The network

Live

60+

institutional investors syndicating and co-investing on Newnex.

Principles

  1. 01

    Syndicate and refer follow-on rounds between GPs. Invite your LPs to co-invest.

    GPs syndicate fundraises and follow-on rounds with peer GPs. Invite your own LPs into deals you're leading.

  2. 02

    LPs refer funds to LPs and co-invest.

    LPs refer fund managers to peer LPs and co-invest in deals run by their managers. Allocator-to-allocator, direct.

  3. 03

    Deals work via peer reference.

    Every deal is referred from a member's portfolio or active investments. No scanning, no screening, no algorithmic matching. You bring the deal, we're the channel.

  4. 04

    Global institutional VC network that compounds.

    Invite peer VCs into the network. Discover institutional GPs across geographies by investment strategy. Built on mutual trust between institutional investors.

How VCs Use Newnex

Three ways to syndicate and co-invest with verified institutional investors.

Expand the network. Start a conversation.

Browse the verified network by strategy, stage, and geography. Send a private message, build the peer relationship first, and invite them to view a deal when the time is right.

  1. 1

    Browse Network

    Discover VCs by sector, stage, and geography

  2. 2

    Send Message

    Introduce yourself and start a private conversation

  3. 3

    Build Trust

    Exchange ideas, share views, find common ground

  4. 4

    Share When Ready

    Invite them to view your deal at the right moment

newnex.io

Maria L. · Alpine Ventures

Hi - saw your profile. We're actively looking at climate tech in Europe. Would love to connect.

You

Thanks Maria! We have a Series A climate deal that might be a fit. Happy to share more details.

Maria L. · Alpine Ventures

Sounds interesting. Could you share the deck when ready?
Type a message...Send

Who it's for

What each tier does here

  • For VCs

    Discover other GPs by strategy. Syndicate a fundraise. Forward deals you're passing.

  • For LPs

    Reference and invest in funds through LP references. Co-invest with your GPs.

  • For Founders

    Reach institutional VCs through warm references from your VC contacts.

From the network

Feed

View All

Team S

@newnexteam

TidalSense Raises $19 Million to Expand AI-Powered Respiratory Diagnostics

Cambridge-based HealthTech company TidalSense has raised $19 million in funding to accelerate the commercialization of its AI-powered respiratory diagnostics platform. The funding brings the company's total funding to approximately $40 million, including previously secured

Team S

@newnexteam

CARPL.ai Raises $10 Million Series A Funding to Scale Healthcare AI Globally

Healthcare AI startup CARPL.ai has raised $10 million in a Series A funding round to accelerate the global adoption of artificial intelligence in medical imaging. The round was led by the International Finance Corporation (IFC), the private-sector investment arm of the World

Team S

@newnexteam

Jusfy Raises Series A Funding to Advance AI-Powered Legal Services

Brazilian LegalTech startup Jusfy has raised a Series A funding round to accelerate the development of its AI-powered legal platform and strengthen its position in Brazil's rapidly evolving legal technology market. The round was led by Maya Capital, with participation from Norte

Team S

@newnexteam

Cashea Raises $100 Million Across Series A and Series B Funding Rounds

Venezuela-based Cashea, a fintech company offering interest-free installment financing, has secured $100 million across its Series A and Series B funding rounds to expand consumer access to credit and strengthen its digital financial services platform across the country. The

Team S

@newnexteam

Crystalys Therapeutics Raises $130 Million in Series B Funding

San Diego-based Crystalys Therapeutics, a clinical-stage biopharmaceutical company focused on developing new treatments for gout, has raised $130 million in a Series B funding round. The financing was led by Frazier Life Sciences, with participation from Wellington Management,

Team S

@newnexteam

Glow Emerges from Stealth with $100 Million Series B at $1.2 Billion Valuation

Glow, an Israel- and U.S.-based AI cybersecurity startup, has emerged from stealth after raising $100 million in a Series B funding round at a $1.2 billion valuation. The round was led by Sequoia Capital, Cyberstarts, Greenoaks, and Redpoint Ventures, with additional

Editorial

News and Views

View All

The network

Investors work privately and confidentially together.

View network

Membership

Join Newnex.

Institutional focused. Invite only. Private by default.

Request invite